176 results on '"Hirosue, Akiyuki"'
Search Results
2. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells
3. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
4. The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation
5. Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis
6. Three-dimensional volumetric analysis of the efficiency of marsupialization in patients with mandibular dentigerous cysts involving impacted third molars
7. Involvement of ferroptosis‐defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma
8. Can MRI-derived depth of invasion predict nodal recurrence in oral tongue cancer?
9. A case of squamous cell carcinoma of mandibular gingiva with treatment-related myelodysplastic syndrome after paclitaxel, carboplatin and cetuximab therapy.
10. FOXP3 lymphocyte status may predict the risk of malignant transformation in oral leukoplakia
11. BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene
12. A Case of Squamous Cell Carcinoma of Mandibular Gingiva With Treatment-related Myelodysplastic Syndrome After Paclitaxel, Carboplatin and Cetuximab Therapy
13. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer
14. Table S1 from Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
15. Figure S1 from Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
16. supplemental legend from Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
17. An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
18. Hyalinizing clear cell carcinoma with EWSR1 rearrangement in an 11-year-old girl
19. Hyalinizing clear cell carcinoma with EWSR1 rearrangement in an 11-year-old girl.
20. Factors Affecting Human Damage in Heavy Rains and Typhoon Disasters
21. Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis
22. miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma
23. A case of drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) following stomatitis
24. Re‑evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice
25. The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma
26. A case of Rosai-Dorfman disease initially suspected to be cervical lymph node metastasis after surgery for tongue cancer
27. A case of Acute Aortic Dissection with Orofacial Pain as the Initial Manifestation
28. A low dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma
29. A case of descending necrotizing mediastinitis arising from odontogenic infection with emergent airway management
30. Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy
31. Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer
32. Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy
33. Quantitative assessment of higher-order chromatin structure of the INK4/ARF locus in human senescent cells
34. A case of sublingual-plunging ranula extending to the supraclavicular fossa and superior mediastinum
35. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Therapy Oncology Group 8502 “QUAD shot” regimen for incurable head and neck cancer
36. Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method
37. Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
38. Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy.
39. Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis
40. Reliability of MRI-Derived Depth of Invasion of Oral Tongue Cancer
41. HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
42. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
43. Elective neck dissection is useful in what cases?
44. Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma
45. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study
46. Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report
47. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia
48. The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells
49. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
50. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.